NYSE · Drug Manufacturers - General

Eli Lilly and Company (LLY)

$1,417.54 +3.19%
78 Overbought Daily RSI (14) · 30 Oct 2026

Moving averages

SMA 50$1,197.14+141,654.00%
SMA 200$1,076.50+141,654.00%
EMA 20$1,266.47+141,654.00%

Company profile

Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.

SectorHealthcare
IndustryDrug Manufacturers - General
Market cap$1.05T
P/E ratio39.59
EPS$29.79
Beta0.453
Dividend yield0.55%
52-week high$1,292.65
52-week low$778.94

Insider transactions

ExecutiveTitleActionSharesDate
SULZBERGER, GABRIELLEDirectorBuy32026-10-19
FYRWALD, J ERIKDirectorBuy72026-10-19
LUCIANO, JUAN RDirectorBuy122026-10-19
Sign in: free for 30 days

Latest news

Earnings call transcript

Q2 2026

Ladies and gentlemen, thank you for standing by, and welcome to the Lilly Q2 2026 Earnings Conference Call. I would now like to turn the conference over to your host, Mike Czapar, Senior Vice President of Investor Relations. Please go ahead.…

Sign in: free for 30 days

Options chain

TypeStrikeExpiryVolumeOpen interest
Put$610.002026-11-065,58140
Call$1,445.002026-10-301,55934
Put$1,400.002026-10-301,49391
Sign in: free for 30 days

ETFs holding LLY

Similar stocks in Drug Manufacturers - General

30 days of PRO Unlimited free, no card

RSI alerts for LLY

An email when LLY closes below RSI 30 or above 70. Nothing else.

Add alert

Data last updated 1 November 2026 at 8:58 PM EST